Skip to content
  • Sunday, 26 July 2026
  • 1:46 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Understanding Osteopenia: The Global Silent Epidemic of Bone Density Loss and the Path to Prevention
Stem Cell & Regenerative Medicine

Understanding Osteopenia: The Global Silent Epidemic of Bone Density Loss and the Path to Prevention

Dwi Wanna Jul 10, 2026 0

The global health landscape is currently grappling with a quiet but pervasive crisis as data reveals that approximately 40% of…

Read More
Environmental & Analytical Chemistry

The Alarming Rise of AI Chatbots in Youth Mental Healthcare: A Silent Epidemic

Abdurrohim Arsyad Jun 1, 2026 0

A growing number of adolescents and young adults are turning to artificial intelligence chatbots for mental health support, a trend…

Read More
Protecting innovation in a borderless pharma economy: The reality of globalized pharma innovationScience News: A Centennial of Illuminating the World of ScienceSpinning Crystals Inside Malaria ParasitesUnveiling the Developmental Architecture of the Hippocampus as a Full Slate Rather Than a Blank Canvas
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ